GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive drug trial seeks to target tough cancers
Disease control TerminatedThis early-stage study tested a new radioactive cancer treatment called [177Lu]Lu-FF58 in patients with advanced pancreatic, stomach, or brain cancers. The main goal was to find a safe dose and see how the body handles the drug. Researchers also used a special imaging scan to see…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug tested as last hope for aggressive brain cancer
Disease control TerminatedThis study tested an experimental drug called VAL-083 for adults with glioblastoma, a fast-growing brain cancer that had returned after standard treatments failed. It compared VAL-083 against a doctor's choice of other approved chemotherapy drugs to see which helped patients live…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Early cancer imaging study halted after limited testing
Diagnosis TerminatedThis was an early, first-in-human study to test a new radioactive imaging agent called [68Ga]-FF58. The goal was to see if it could safely and effectively highlight specific aggressive cancers (like glioblastoma and pancreatic cancer) during PET scans. The study was terminated ea…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC
-
Old drug, new target: can a common pill fight deadly brain cancer?
Knowledge-focused TerminatedThis very early study aimed to see if ketoconazole, a drug used for fungal infections, could get into brain tumors at high enough levels to potentially stop cancer cell growth. Researchers planned to measure drug levels directly in the tumor tissue of a small number of adults wit…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Fungal infection drug tested as potential brain tumor fighter
Knowledge-focused TerminatedThis small, early-stage study tested whether a common antifungal drug called posaconazole can get into brain tumors at high enough levels to potentially stop cancer cells from growing. Researchers gave the drug to a few adults with a type of aggressive brain cancer before their s…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC